All News

2070 articles, sorted by publication time.

Biotechnology · global

Whole-Genome Data Moves Into Oncology Drug Development as Inocras and AimedBio Form Alliance

The collaboration connects cancer genome interpretation and candidate drug development within the same R&D chain, aiming to shorten the distance from patient data to clinical trial design; but with limited public information available, whether it can truly accelerate new therapies will still depend on data quality, target validation, and clinical results.

biotech · global

Glenmark Advances Phase 3 Trial of HER2 Antibody-Drug Conjugate, Adding a Key Test for Drug-Resistant Ovarian Cancer Treatment

After platinum-based drugs fail, ovarian cancer treatment often enters a narrow path with limited options. Glenmark is moving its HER2-targeted ADC into late-stage clinical development; the real question is not whether the concept is novel, but whether it can produce evidence strong enough to change treatment sequencing in a difficult-to-treat population.